Search Results

5′-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.

• Authors : Henderson, Gary B.; Stein, C. A.

• Source: Nucleic Acids Research; 9/15/1995, Vol. 23 Issue 18, p3726-3731, 6p

Record details

Methotrexate toxicity treated with continuous venovenous hemofiltration, leucovorin and glucarpidase.

• Authors : Connors, Nicholas J.; Sise, Meghan E.; Nelson, Lewis S.

Subjects: METHOTREXATE; DRUG side effects; LYMPHOMA treatment

• Source: Clinical Kidney Journal; Dec2014, Vol. 7 Issue 6, p590-592, 3p

Record details

Methotrexate toxicity precipitated by azapropazone.

• Authors : Daly, Helena M.; Scott, G.L.; Boyle, J.

Subjects: ANTINEOPLASTIC agents; IMMUNOSUPPRESSIVE agents; NONSTEROIDAL anti-inflammatory agents

• Source: British Journal of Dermatology; Jun1986, Vol. 114 Issue 6, p733-735, 3p

Record details

Pancytopenia, mucositis, and hepatotoxicity after intralesional methotrexate injection in a patient treated with peritoneal dialysis.

• Authors : FLYNN, KIMBERLY N.; JOHNSON, MARK S.; BRINK, WILLIAM C.

Subjects: PERITONEAL dialysis; HEPATOTOXICOLOGY -- Risk factors; STOMATITIS

• Source: American Journal of Health-System Pharmacy. 4/1/2012, Vol. 69 Issue 7, p578-582. 5p.

Record details

Glucarpidase for the management of elevated methotrexate levels in patients with impaired renal function.

• Authors : FERMIANO, MARIANA; BERGSBAKEN, JASON; KOLESAR, JILL M.

Subjects: METHOTREXATE; KIDNEY failure; PROTEOLYTIC enzymes

• Source: American Journal of Health-System Pharmacy. 5/15/2014, Vol. 71 Issue 10, p793-798. 6p. 1 Chart.

Record details

Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma.

• Authors : Zhang, Joy C; Stotts, Matthew J; Horton, Bethany

Subjects: CENTRAL nervous system; HEPATOTOXICOLOGY; METHOTREXATEUNIVERSITY of Virginia

• Source: Neuro-Oncology Practice; Jun2023, Vol. 10 Issue 3, p291-300, 10p

Record details

Evaluating off-label uses of acetazolamide.

• Authors : Berkel, Megan A. Van (AUTHOR); Elefritz, Jessica L. (AUTHOR)

Subjects: ACETAZOLAMIDE; ALKALOSIS; INTRACRANIAL hypertension

• Source: American Journal of Health-System Pharmacy. 4/15/2018, Vol. 75 Issue 8, p524-531. 8p.

Record details

A case of methotrexate intoxication in a patient with psoriasis who drank beetroot juice during methotrexate treatment.

• Authors : Gönül, M.¹; Keseroglu, H.¹; Hacınecipoğlu, F.¹

Subjects: *METHOTREXATE; *BEET juice; *PSORIASIS

• Source: Clinical & Experimental Dermatology. Dec2016, Vol. 41 Issue 8, p893-895. 3p.

Record details

Intrathecal methotrexate, central nervous system toxicity, and response to N-methyl-D-aspartate antagonism: An adult case series.

• Authors : Donaghy, Ryan¹ (AUTHOR) ; Singer, Lauren² (AUTHOR); Dixit, Karan¹ (AUTHOR)

Subjects: *MAGNETIC resonance imaging; *CENTRAL nervous system; *WHITE matter (Nerve tissue)

• Source: Neuro-Oncology Practice. Oct2024, Vol. 11 Issue 5, p665-669. 5p.

Record details

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.

• Authors : Mercer, Louise; Abhishek, Abhishek; Kavirayani, Akhila

Subjects: ANTIRHEUMATIC agents; RHEUMATOLOGY; RHEUMATISM

• Source: Rheumatology Advances in Practice; 2024, Vol. 8 Issue 3, p1-5, 5p

Record details